PML/RARα+ U937 mutant and NB4 cell lines

Retinoic acid restores the monocytic differentiation response to vitamin D3

Ugo Testa, Francesco Grignani, Tiziano Barberi, Marta Fagioli, Rosalba Masciulli, Pier Francesco Ferrucci, Davide Seripa, Antonio Camagna, Myriam Alcalay, Pier Giuseppe Pelicci, Cesare Peschle

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

We have analyzed the differentiation program of a U937 promonocytic leukemia clone transduced with the acute promyelocytic leukemia specific PML/RARα fusion gene, the expression of which is under the control of the inducible metallothionine (MT) I promoter (MTPR9 clone). MTPR9 cells treated with Zn2+ hence exhibit levels of PML-RARα protein as high as fresh acute promyelocytic leukemia blasts. In the absence of Zn2+, i.e., upon low level PML/RARα expression, 1,25-dihydroxyvitamin D3 (D3) and particularly D3 plus transforming growth factor β1 (TGF-β1) induced terminal differentiation of MTPR9 cells (as observed in 'wild-type' U937 cells), on the basis of morphology, membrane antigen pattern, and functional criteria. Conversely, in the presence of Zn2+, D3 and D3 plus TGF-β1 failed to induce terminal differentiation, as evaluated by the above parameters. Interestingly, retinoic acid (RA) treatment suppresses the differentiation blockade induced by high level PML-RARα protein; indeed, Zn2+-treated MTPR9 cells incubated with RA plus D3 exhibited significant terminal monocytic maturation, comparable to that of cells treated with D3 alone or combined with RA in absence of Zn2+. Similar observations were made in NB4, a PML-RAR+ human acute leukemic line. As expected RA treatment of NB4 cells causes granulocytic differentiation. Interestingly, the cell line is only scarcely induced to mature monocytic cells by D3 or D3 plus TGF-β1 treatment, whereas it is effectively induced to monocytic maturation by combined treatment with D3 and RA. Accordingly, the rate of NB4 cell proliferation is only slightly affected by D3 or D3 plus TGF-β1 treatment, mildly inhibited by RA, and markedly decreased by D3 plus RA. These results indicate that in both U937 and NB4 cells high level PML/RARα expression inhibits the monocytic terminal differentiation program triggered by D3 or D3 plus TGF- β1, whereas RA treatment effectively antagonizes this inhibitory PML-RARα action and restores the D3 differentiative effect.

Original languageEnglish
Pages (from-to)4508-4515
Number of pages8
JournalCancer Research
Volume54
Issue number16
Publication statusPublished - Aug 15 1994

Fingerprint

Cholecalciferol
Tretinoin
Cell Line
Transforming Growth Factors
U937 Cells
Acute Promyelocytic Leukemia
Clone Cells
Calcitriol
Cell Differentiation
Leukemia
Proteins
Cell Proliferation
Gene Expression
Antigens
Membranes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Testa, U., Grignani, F., Barberi, T., Fagioli, M., Masciulli, R., Ferrucci, P. F., ... Peschle, C. (1994). PML/RARα+ U937 mutant and NB4 cell lines: Retinoic acid restores the monocytic differentiation response to vitamin D3. Cancer Research, 54(16), 4508-4515.

PML/RARα+ U937 mutant and NB4 cell lines : Retinoic acid restores the monocytic differentiation response to vitamin D3. / Testa, Ugo; Grignani, Francesco; Barberi, Tiziano; Fagioli, Marta; Masciulli, Rosalba; Ferrucci, Pier Francesco; Seripa, Davide; Camagna, Antonio; Alcalay, Myriam; Pelicci, Pier Giuseppe; Peschle, Cesare.

In: Cancer Research, Vol. 54, No. 16, 15.08.1994, p. 4508-4515.

Research output: Contribution to journalArticle

Testa, U, Grignani, F, Barberi, T, Fagioli, M, Masciulli, R, Ferrucci, PF, Seripa, D, Camagna, A, Alcalay, M, Pelicci, PG & Peschle, C 1994, 'PML/RARα+ U937 mutant and NB4 cell lines: Retinoic acid restores the monocytic differentiation response to vitamin D3', Cancer Research, vol. 54, no. 16, pp. 4508-4515.
Testa, Ugo ; Grignani, Francesco ; Barberi, Tiziano ; Fagioli, Marta ; Masciulli, Rosalba ; Ferrucci, Pier Francesco ; Seripa, Davide ; Camagna, Antonio ; Alcalay, Myriam ; Pelicci, Pier Giuseppe ; Peschle, Cesare. / PML/RARα+ U937 mutant and NB4 cell lines : Retinoic acid restores the monocytic differentiation response to vitamin D3. In: Cancer Research. 1994 ; Vol. 54, No. 16. pp. 4508-4515.
@article{75db1195571d4a21ae955ab37b012608,
title = "PML/RARα+ U937 mutant and NB4 cell lines: Retinoic acid restores the monocytic differentiation response to vitamin D3",
abstract = "We have analyzed the differentiation program of a U937 promonocytic leukemia clone transduced with the acute promyelocytic leukemia specific PML/RARα fusion gene, the expression of which is under the control of the inducible metallothionine (MT) I promoter (MTPR9 clone). MTPR9 cells treated with Zn2+ hence exhibit levels of PML-RARα protein as high as fresh acute promyelocytic leukemia blasts. In the absence of Zn2+, i.e., upon low level PML/RARα expression, 1,25-dihydroxyvitamin D3 (D3) and particularly D3 plus transforming growth factor β1 (TGF-β1) induced terminal differentiation of MTPR9 cells (as observed in 'wild-type' U937 cells), on the basis of morphology, membrane antigen pattern, and functional criteria. Conversely, in the presence of Zn2+, D3 and D3 plus TGF-β1 failed to induce terminal differentiation, as evaluated by the above parameters. Interestingly, retinoic acid (RA) treatment suppresses the differentiation blockade induced by high level PML-RARα protein; indeed, Zn2+-treated MTPR9 cells incubated with RA plus D3 exhibited significant terminal monocytic maturation, comparable to that of cells treated with D3 alone or combined with RA in absence of Zn2+. Similar observations were made in NB4, a PML-RAR+ human acute leukemic line. As expected RA treatment of NB4 cells causes granulocytic differentiation. Interestingly, the cell line is only scarcely induced to mature monocytic cells by D3 or D3 plus TGF-β1 treatment, whereas it is effectively induced to monocytic maturation by combined treatment with D3 and RA. Accordingly, the rate of NB4 cell proliferation is only slightly affected by D3 or D3 plus TGF-β1 treatment, mildly inhibited by RA, and markedly decreased by D3 plus RA. These results indicate that in both U937 and NB4 cells high level PML/RARα expression inhibits the monocytic terminal differentiation program triggered by D3 or D3 plus TGF- β1, whereas RA treatment effectively antagonizes this inhibitory PML-RARα action and restores the D3 differentiative effect.",
author = "Ugo Testa and Francesco Grignani and Tiziano Barberi and Marta Fagioli and Rosalba Masciulli and Ferrucci, {Pier Francesco} and Davide Seripa and Antonio Camagna and Myriam Alcalay and Pelicci, {Pier Giuseppe} and Cesare Peschle",
year = "1994",
month = "8",
day = "15",
language = "English",
volume = "54",
pages = "4508--4515",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "16",

}

TY - JOUR

T1 - PML/RARα+ U937 mutant and NB4 cell lines

T2 - Retinoic acid restores the monocytic differentiation response to vitamin D3

AU - Testa, Ugo

AU - Grignani, Francesco

AU - Barberi, Tiziano

AU - Fagioli, Marta

AU - Masciulli, Rosalba

AU - Ferrucci, Pier Francesco

AU - Seripa, Davide

AU - Camagna, Antonio

AU - Alcalay, Myriam

AU - Pelicci, Pier Giuseppe

AU - Peschle, Cesare

PY - 1994/8/15

Y1 - 1994/8/15

N2 - We have analyzed the differentiation program of a U937 promonocytic leukemia clone transduced with the acute promyelocytic leukemia specific PML/RARα fusion gene, the expression of which is under the control of the inducible metallothionine (MT) I promoter (MTPR9 clone). MTPR9 cells treated with Zn2+ hence exhibit levels of PML-RARα protein as high as fresh acute promyelocytic leukemia blasts. In the absence of Zn2+, i.e., upon low level PML/RARα expression, 1,25-dihydroxyvitamin D3 (D3) and particularly D3 plus transforming growth factor β1 (TGF-β1) induced terminal differentiation of MTPR9 cells (as observed in 'wild-type' U937 cells), on the basis of morphology, membrane antigen pattern, and functional criteria. Conversely, in the presence of Zn2+, D3 and D3 plus TGF-β1 failed to induce terminal differentiation, as evaluated by the above parameters. Interestingly, retinoic acid (RA) treatment suppresses the differentiation blockade induced by high level PML-RARα protein; indeed, Zn2+-treated MTPR9 cells incubated with RA plus D3 exhibited significant terminal monocytic maturation, comparable to that of cells treated with D3 alone or combined with RA in absence of Zn2+. Similar observations were made in NB4, a PML-RAR+ human acute leukemic line. As expected RA treatment of NB4 cells causes granulocytic differentiation. Interestingly, the cell line is only scarcely induced to mature monocytic cells by D3 or D3 plus TGF-β1 treatment, whereas it is effectively induced to monocytic maturation by combined treatment with D3 and RA. Accordingly, the rate of NB4 cell proliferation is only slightly affected by D3 or D3 plus TGF-β1 treatment, mildly inhibited by RA, and markedly decreased by D3 plus RA. These results indicate that in both U937 and NB4 cells high level PML/RARα expression inhibits the monocytic terminal differentiation program triggered by D3 or D3 plus TGF- β1, whereas RA treatment effectively antagonizes this inhibitory PML-RARα action and restores the D3 differentiative effect.

AB - We have analyzed the differentiation program of a U937 promonocytic leukemia clone transduced with the acute promyelocytic leukemia specific PML/RARα fusion gene, the expression of which is under the control of the inducible metallothionine (MT) I promoter (MTPR9 clone). MTPR9 cells treated with Zn2+ hence exhibit levels of PML-RARα protein as high as fresh acute promyelocytic leukemia blasts. In the absence of Zn2+, i.e., upon low level PML/RARα expression, 1,25-dihydroxyvitamin D3 (D3) and particularly D3 plus transforming growth factor β1 (TGF-β1) induced terminal differentiation of MTPR9 cells (as observed in 'wild-type' U937 cells), on the basis of morphology, membrane antigen pattern, and functional criteria. Conversely, in the presence of Zn2+, D3 and D3 plus TGF-β1 failed to induce terminal differentiation, as evaluated by the above parameters. Interestingly, retinoic acid (RA) treatment suppresses the differentiation blockade induced by high level PML-RARα protein; indeed, Zn2+-treated MTPR9 cells incubated with RA plus D3 exhibited significant terminal monocytic maturation, comparable to that of cells treated with D3 alone or combined with RA in absence of Zn2+. Similar observations were made in NB4, a PML-RAR+ human acute leukemic line. As expected RA treatment of NB4 cells causes granulocytic differentiation. Interestingly, the cell line is only scarcely induced to mature monocytic cells by D3 or D3 plus TGF-β1 treatment, whereas it is effectively induced to monocytic maturation by combined treatment with D3 and RA. Accordingly, the rate of NB4 cell proliferation is only slightly affected by D3 or D3 plus TGF-β1 treatment, mildly inhibited by RA, and markedly decreased by D3 plus RA. These results indicate that in both U937 and NB4 cells high level PML/RARα expression inhibits the monocytic terminal differentiation program triggered by D3 or D3 plus TGF- β1, whereas RA treatment effectively antagonizes this inhibitory PML-RARα action and restores the D3 differentiative effect.

UR - http://www.scopus.com/inward/record.url?scp=0028168401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028168401&partnerID=8YFLogxK

M3 - Article

VL - 54

SP - 4508

EP - 4515

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 16

ER -